Background: Transhydrogenase, located in the inner membranes of animal mitochondria and the cytoplasmic membranes of bacteria, couples the transfer of reducing equivalents between NAD(H) and NADP(H) to proton pumping. The protein comprises three subunits termed dI, dII and dIII. The dII component spans the membrane. The dI component, which contains the binding site for NAD + /NADH, and the dIII component, which has the binding site for NADP + /NADPH, protrude from the membrane. Proton pumping is probably coupled to changes in the binding affinities of dIII for NADP + and NADPH.
Introduction
The living cell maintains its pools of NAD(H) and NADP(H) at different redox potentials to allow independent control of catabolism and biosynthesis. NAD + is the predominant soluble electron acceptor in catabolism and under aerobic conditions its reduced form, NADH, can subsequently provide electrons to the respiratory chain. On the other hand, the major supplier of reducing power in biosynthesis is NADPH. Transhydrogenase, which catalyses the transfer of reducing equivalents between NAD(H) and NADP(H), occupies the interface between the two nicotinamide nucleotide pools, but not in an unrestricted way. Its chemical reaction is coupled to the translocation of H + across a cell membrane.
(1) Located in the inner mitochondrial membrane of animal cells and the cytoplasmic membrane of bacterial cells, transhydrogenase is driven to the right (Equation 1) by the proton electrochemical gradient (∆p) that results from the action of the respiratory chain or, in some organisms, the photosynthetic electron transport chain. In bacteria, this action of transhydrogenase is thought to be partly responsible for the provision of reducing power for amino acid biosynthesis and detoxification [1] . In animal mitochondria, similar pathways might operate but the situation is more complex [2] . Here, it is probable that the main function of transhydrogenase, acting in combination with the NAD-and NADP-linked isocitrate dehydrogenases, is to control flux through the tricarboxylic acid cycle [3] .
Transhydrogenase is often described as a proton pump because, operating in the reverse direction (see Equation 1 ), the enzyme generates rather than consumes ∆p. One H + is translocated across the membrane for each hydride equivalent transferred between nucleotides (χ = 1 in Equation 1 [4] ). As an ion pump, however, transhydrogenase is unusual in that the difference between the standard Gibbs free energy of the nucleotide reactants and products is close to zero; the energy used to generate ∆p is
solely derived from the concentration terms of reactants and products in the same aqueous phase. As with many other biological ion pumps, an understanding of the mechanism by which the scalar chemistry (of transhydrogenation in this case) is coupled to vectorial proton translocation is limited by the lack of information on the protein structure.
Transhydrogenase has a tripartite arrangement of subunits. The dII component spans the membrane and the dI and dIII components protrude from the membrane (on the matrix side in mitochondria). The binding site for NAD + and NADH is located on dI, and that for NADP + and NADPH is located on dIII. Recombinant forms of dI and dIII from transhydrogenases of a number of species have been prepared and found to bind their cognate nucleotides (see [5] for references). Simple mixtures of the dI and dIII proteins catalyse transhydrogenation but at a very low rate. Although the hydride transfer step, at least in some recombinant dI-dIII complexes, is fast [6, 7] , the overall steady-state rate of reaction is limited by very slow release of product NADPH (in the forward direction) and NADP + (in the reverse direction) [8] . It was proposed that the slow release of nucleotides from isolated dIII and from dI-dIII complexes results from the absence of interaction with dII. This is consistent with a 'binding-change' mechanism of energy coupling in transhydrogenase (so-called because of an analogy with that described for the F 0 F 1 -ATPase [9] ). In our version of this mechanism, protonation and deprotonation of dII (or dII-dIII), on opposite sides of the membrane, lead to conformational changes in dIII, which promote a switch in the NADP +and NADPH-binding affinities and thus drive the reaction to the right in Equation 1 [10, 11] . NADH is effectively a passive donor of reducing equivalents [12, 13] . Other versions of the binding-change mechanism have been outlined, in which events at both the NAD(H) and NADP(H) sites are coupled to H + translocation [14, 15] .
In this report, we describe the high-resolution crystal structure of the recombinant dIII component of human transhydrogenase in its NADP + -bound form. Structural features indicate how it might interact with dI and dII, and provide an insight as to how changes in the binding affinity of dIII for NADP + and NADPH might be coupled to proton translocation.
Results and discussion
The protein fold
The dIII component of human transhydrogenase (Figure 1 ) folds into a single, compact domain ~34 × 35 × 50 Å. The overall fold (Figure 2a ) resembles the dinucleotide-binding fold, or Rossmann fold, found in many soluble dehydrogenases [16] . Thus, the protein comprises an open, twisted β sheet of six parallel strands (β1 to β6), flanked by helices (0 and A to F). As in the classical lactate dehydrogenase (LDH) structure, two βαβαβ motifs can be distinguished. The N-terminal strands of each of the two motifs lie in the centre of the sheet. The associated helices in the first motif are folded on the opposite side of the sheet to those in the second motif, giving rise to a line of pseudo-symmetry between the two units. A 'cross-over' helix, helix C, which has a predominantly 3 10 character, links the C terminus of strand β3 with the N terminus of strand β4. One extra α helix, helix 0, preceding strand β1, passes down the 'back' of the molecule and packs against the N-terminal ends of strands β6, β5, β4 and β1. Another helix, helix F, at the C terminus of β6, also runs down the back and packs between helix 0 and helix A. The first two helices in the second βαβαβ unit are considerably distorted. The segment designated helix D/loop D is a very distinctive feature. The polypeptide chain turns from the carboxyl end of β4, at the invariant Gly964, and with a single turn of 3 10 helix followed by a single turn of α helix it protrudes at the front of the molecule, almost perpendicular to the sheet, before terminating in three consecutive β turns between Asp976 and Met984. The polypeptide chain then passes back, towards the β sheet, to be followed by a short segment of 3 10 helix (helix D′), which passes under the protruding structure to connect with the N terminus of 2 Structure 2000, Vol 8 No 1
Figure 1
Amino acid sequence and secondary structure elements of the dIII component of human transhydrogenase. Met837 of the complete, mature enzyme from human heart mitochondria [59] is the N-terminal methionine of the recombinant dIII protein [5] . Underlined residues are invariant in ten other published sequences of the dIII region of transhydrogenase from both animal and bacterial species. The apparent 'fingerprint', Gly-X-Gly-X-X-Ala/Val, is from residues 889-894. The positions of helices (red rectangles) and β strands (green arrows) were derived by PROCHECK analysis [60] . strand β5. At the C terminus of this strand, a long loop (loop E) passes over the protruding helix D/loop D and over the bound nucleotide. Another short stretch of 3 10 helix joins loop E to β6. With the exception of amino acid residues 859-866 and a few sidechains, there is good noncrystallographic symmetry between the two monomers in the asymmetric unit (root mean square deviation [rmsd] between the two monomers is 0.252 Å calculated using 180 equivalent Cα atoms).
In ten other published amino acid sequences of transhydrogenases, 53 residues out of approximately 205 are invariant. These conserved residues cluster in several regions: at the N terminus, where the polypeptide chain emerges from the last transmembrane helix of dII; in the turn at the C terminus of β1; in the nicotinamide-binding turn at the C terminus of β2; in helix B; in helix D/loop D; and in loop E. These clusters are expected to be important for catalysis.
Dinucleotide binding
Of the large number of proteins that utilise NAD(P)(H), by far the majority bind the nucleotide in a Rossmann fold [16] [17] [18] (exceptions, having 'non-classical' binding, are reviewed in [19] ). Two subgroups of Rossmann-fold structures were identified -LDH-like and glutathione reductase-like -but both bind NAD(P)(H) in essentially the same way [19] . Although different combinations of sidechains are involved in specific contacts, the nucleotides in the known structures were always observed to bind at the C-terminal edge of the β sheet, such that the adenosine lies in a cleft between β1 and β2 and the pyrophosphate group makes contact with the loop between β1 and helix A. This loop contains the Gly-X-Gly-X-X-Gly of the 'fingerprint region'. More recently, two variations on the classical theme have been described. Interaction of NAD(H) and the Rossmann fold of aldehyde dehydrogenase is through a 'β4-αD-β2 motif' [20] ; not unexpectedly, this protein does not have the Gly-X-Gly-X-X-Gly sequence in the first βαβ unit. Dehydroquinate synthase has a five-stranded Rossmann fold, comprising a βαβ unit followed by a βαβαβ motif [21] . The pyrophosphate group binds across the glycine-rich first turn in the βαβαβ motif, such that the adenosine moiety is in a cleft located between its first and second strands. Transhydrogenase dIII has a more surprising nucleotide-binding mode. It has a strong resemblance to the classical LDH-like fold, and has a conserved Gly-X-Gly-X-X-Ala/Val sequence in the fingerprint region in the loop between β1 and helix A. It binds NADP + at the C-terminal edge of the β sheet but with an approximately 180° reverse orientation; the adenosine moiety is located predominantly within the second βαβαβ motif and the nicotinamide mononucleotide (NMN) within the first. The overall fold of transhydrogenase dIII. (a) Stereoview Cα trace with every tenth Cα atom highlighted. The figure was constructed using TURBO-FRODO [51] . (b) Ribbon diagram constructed using MOLSCRIPT [61] . The nucleotide is shown in ball-and-stick representation; NIC, nicotinamide ring. Features indicating that the nucleotide-binding properties of the first and second βαβαβ motifs have been reversed, relative to the classical LDH fold, are as follows. Firstly, the cleft for the adenine ring is between the C termini of β4 and β5, where helix F turns away from the back of the sheet. In the classical LDH fold, the crossover region, helix C, creates the cleft between the C termini of β1 and β2. Secondly, the cleft for the adenosine moiety is enlarged because β4 terminates before the adjacent strands β1 and β5. In the LDH-like structures, β1 often terminates before β2 and β4 [18] . Thirdly, residues binding the 2′-phosphate group of NADP + are located in the C-terminal loop of β5. In classical dehydrogenases that bind NADP(H), residues binding the 2′-phosphate are usually located at the C terminus of β2. Fourthly, the pyrophosphate group of NADP + is hydrogen bonded via mainchain amides to the N-terminal residues of helix D. Helix A is the 'pyrophosphate-binding helix' in the classical Rossmann fold.
Thus, the adenosine lies in a cleft positioned over the C termini of strands β4 and β5 and ending where helix E peels away to the back of the molecule. The pyrophosphate group runs across the turn between β4 and helix D, and the nicotinamide ring is located within the loop between β2 and helix B. Loop E arches up over the pyrophosphate group and the ribose of the nicotinamide to form a 'lid' across the bound nucleotide ( Figure 2b) .
A portion of the electron-density map illustrating the conformation of the nucleotide and a selection of important adjacent residues is shown in Figure 3 . As in most nucleotide-binding proteins [18] , the NADP + is in an extended conformation (~13.4 Å from adenine N9 to nicotinamide N1). The adenine ring is in the anti conformation relative to its ribose; the nicotinamide ring is in the syn conformation.
Specificity of the bound NADP + and stereochemistry of hydride transfer
The complex set of interactions between Lys999, Arg1000 and Ser1001, and the 2′-phosphate of the nucleotide ( Refined electron-density map of bound NADP + . SIGMAA-weighted 2mF o -DF c electron density contoured at 1σ. The diagram was constructed from the final model at 2.0 Å resolution using TURBO-FRODO [50] .
Figure 4
Hydrogen bond and van der Waals contacts between NADP + and dIII. The figure was constructed on subunit 1 using LIGPLOT [62] . Mse, selenomethionine; Gol, glycerol. Hydrogen bonds are shown as dashed green lines and van der Waals interactions by red shading; atoms are in standard colours. The adenine-ring system is in van der Waals contact with sidechains in the C-terminal loops of strands β1, β5 and β6. The nicotinamide ring is bound by amino acid residues in the C-terminal loop of β2. Apart from its contact with the bound glycerol molecule, the NMN ribose is hydrogen bonded only by Arg925 and Asp967. There are potentially seven hydrogen bonds between the protein (Lys999, Arg1000 and Ser1001) and the 2′-phosphate of the adenosine ribose. The two negative charges on the 2′-phosphate are, thus, compensated by the positive charges on the lysine and arginine sidechains. The 2′-phosphate is also hydrogen bonded to a bound water molecule. In addition to Gly924, from the nicotinamidebinding loop, there are two sets of residues which form hydrogen-bond contacts with the pyrophosphate group: Asn966, Asp967 and Thr968 from the N terminus of the protruding helix D; and Tyr890 and Arg925, which form part of an interacting triad of residues linking the nicotinamide-binding site with the lid-like loop E. relative to NAD(H) [22, 23] . The stability of this region, reinforced because the C-terminal residue of β5 (Lys999) is hydrogen bonded to residues in adjacent strands of the β sheet and to Ser1001, indicates that it might serve as a fulcrum for conformational changes associated with switching the NADP(H)-binding affinity as loop E opens and closes during catalysis (see below). The importance of these residues in catalysis and nucleotide binding was demonstrated by site-directed mutagenesis [24] . Substitution of the Lys999 and Arg1000 equivalents in Escherichia coli transhydrogenase with cysteine, led to inhibition of reverse transhydrogenation by 70% and 90%, respectively, and increased the K m value for NADPH by threefold and ninefold, respectively.
The nicotinamide ring is bound to the C-terminal loop of β2, with its proR face effectively shielded from the solvent by the polypeptide backbone of residues Gly924 to Met926 ( Figure 5 ). The carbonyl oxygen atoms of Gly924 and Arg925 are both close enough to form an electrostatic interaction with the ring, and Arg925 Cα is in van der Waals contact with nicotinamide atoms NC3 and NC7, all on the proR face. On the proS face the invariant Val922 is in van der Waals contact with NC2 and NC3 (weaker contact in monomer 2 than monomer 1), but other ring atoms, including NC4, are exposed to the solvent. In the complete enzyme, the nicotinamide ring is brought into apposition with the dihydronicotinamide ring of NADH on dI to effect a direct transfer of hydride equivalent between the two C4 atoms [6, 7, 25] . It is probable that this mutual positioning will involve the mainly exposed proS face of the nicotinamide ring of NADP + and, therefore, that Hwill be transferred to the B position of its NC4, explaining the well-known stereochemistry at this site [26] .
The fingerprint region and nucleotide binding
The function of the glycine-rich sequence in the first βαβ region of the classical dinucleotide-binding fold has been described in detail [17, 19, 27] . In dIII, however, the Gly-X-Gly-X-X-Ala/Val sequence (see Figure 1 ) has adopted a different function. The first glycine, at position 889, has an extended conformation that is required for the correct positioning of Tyr890 at the end of the strand (see below); it does not make a sharp bend to direct the polypeptide chain under the bound nucleotide. The importance of this residue in dIII is signified by the observation that even conservative substitution of its equivalent in E. coli transhydrogenase gives an inactive protein [28] . The second glycine (position 891) makes van der Waals contacts with the adenine ring; it is not required for the approach of the pyrophosphate, which is ~5.9 Å away. In classical dehydrogenases that bind NADP(H) as distinct from NAD(H), the third glycine residue in the fingerprint region is often replaced by an alanine or a valine, although the functional significance of this is unclear [29, 30] ; in dIII, the Cα atom of Ala894 is > 10 Å from the 2′-phosphate group.
The β4-D-β5 motif in dIII has the equivalent role in nucleotide binding to the β1-αA-β2 motif of the classical Rossmann fold. The sequence in the β4-D turn of dIII is highly conserved in transhydrogenases from different species, but is only weakly related to the classical fingerprint region. Gly964 has the same function as the first glycine in a classical fingerprint; it is positioned at a 90°t urn to allow the polypeptide chain to pass under the pyrophosphate group of the bound nucleotide. Asn966 has a similar role to the second glycine in the classical fingerprint; it permits approach of the pyrophosphate to the protein backbone ( Figure 5 ). The residue in the β4-D turn of dIII that is in the equivalent position to the last glycine in the fingerprint is not conserved (valine, isoleucine, or threonine in published sequences) and does not have an obvious function in nucleotide binding.
A search of the Protein Data Bank (PDB) using the program CE [31] showed dIII to have a similar fold to that of the Research Article Structure of transhydrogenase dIII White et al. 5
Figure 5
The NADP + -binding pocket of dIII. Amino acid residues are shown with atoms in standard colours: C, yellow; O, red; and N, blue. The nucleotide is shown in red. NIC, nicotinamide ring; ADE, adenine ring.
FAD-binding domain of pyruvate oxidase (POX; Figure 6 ) [32, 33] . Similarities were also found with sequence-related domains of enzymes of the same family that do not bind FAD, specifically, benzoylformate decarboxylase, pyruvate decarboxylase and transketolase. POX is remarkable in that it binds FAD with two βαβαβ units. There are several classes of protein structure that bind FAD [34] but, apart from POX, only the fold typified by that in glutathione reductase utilises the βαβαβ motif. There, the ADP moiety of the FAD binds to a single βαβαβ motif (usually associated with one or two extra parallel strands with connectivities to other parts of the protein). Within this single motif there is a Gly-X-Gly-X-X-Gly fingerprint at the β1-αA turn, which has the same function in its interaction with adenosine as that in the classical NAD(P)(H)-binding fold. Interestingly, POX not only utilises two βαβαβ units to bind FAD, but, as in dIII, the adenosine is bound to the second rather than the first of the two units.
In POX there is no Gly-X-Gly-X-X-Gly fingerprint in either the first or the second βαβαβ unit. It is all the more remarkable, therefore, that dIII does have the sequence (in its modified form) in the first (nonpyrophosphatebinding) motif. The most probable explanation is that dIII has evolved from an ancestral form that bound nucleotide in the classical mode. Following a reversal of binding orientation, the fingerprint sequence was retained and individual residues adapted to fit new functions (as above). Less probable is the possibility that glycine residues (or alanine/valine) have independently arisen at the β1 to helix A turn in identical positions to those in the Rossmann structure, but to suit different functions. The difference in the sequences indicates that the similarity between the folds of dIII and POX has arisen by convergent evolution. There is no evidence in POX, however, as to whether or not an ancestral form of the protein possessed a fingerprint in its N-terminal βαβαβ unit.
The binding of dIII to dI and dII
In a homology model of dI [35] , built on the basis of comparisons with the structure of alanine dehydrogenase [36] , the nicotinamide ring of NADH is located at the bottom of a cleft separating domain dI.1 from domain dI.2. In contrast, the nicotinamide ring of NADP + in dIII is exposed at one end of a ridge dividing two relatively flat protein surfaces (Figure 7) . It is probable that, in the complete enzyme, the ridge of dIII is inserted into the putative cleft of dI to bring the C4 atoms of the two nicotinamide rings into apposition to permit hydride transfer [6, 7, 25] . Support for this positioning was obtained in a recent nuclear magnetic resonance (NMR) experiment, in which chemicalshift changes in the backbone amides of Rhodospirillum rubrum dIII upon addition of dI were almost completely confined to the regions that we can now see correspond to the two, ridge-adjacent surfaces [37] . Only low-affinity interactions were detected in these experiments; changes in chemical shift resulting from high-affinity interactions were obscured by resonance broadening.
The 'back' of dIII is covered by the three amphipathic helices, 0, A and F. The exposed surface of these helices is highly polar and has few conserved residues. This region is, therefore, probably also in contact with the solvent in the complete protein. Taken together with the likely site of interaction with dI (covering the C-terminal loops of the β strands and the outer edge of the first βαβαβ motif), this suggests that the transmembrane dII must interact with the 'front' of dIII, in the region of the protruding helix D/loop D. In intact transhydrogenase, the N terminus of dIII is directly connected to dII through the polypeptide chain, but the segment that emerges from the membranespanning component is disordered in the X-ray structure (residues 837-858) and according to NMR data [37] . It comprises mostly small polar amino acid residues, and in the detergent-solubilised complete enzyme is susceptible Superimposition of POX and dIII. The alignment was established as indicated in the text. The Cα atoms of dIII (yellow) and POX (blue) superimpose with an rmsd of 1.06 Å using 86 pairs of equivalent Cα atoms. There is no sequence similarity between dIII and POX, except in the region of strand 4 where in all available sequences of both proteins there is a glycine residue (position 964 in human dIII), which allows for a 90° turn of the polypeptide chain under the nucleotide pyrophosphate (see text and [33] ), and an aspartate residue (at the N terminus of the strand) for which a specific function is not yet ascribed. There is an analogous conserved charged residue at the N terminus of strand 1 in the classical dinucleotide-binding proteins, which has no known function [19] . In contrast to LDH-like structures, POX does not have a pyrophosphate-binding α helix; in dIII, the pyrophosphate-binding helix D also has a rather loose structure, with its first turn in a 3 10 configuration.
to cleavage by proteases [38, 39] , suggesting that this linker region is somewhat flexible.
Interactions between bound dinucleotide, helix D/loop D and loop E
Isolated dIII binds NADP + and NADPH extremely tightly [5, 8] , the K d (≤ 10 -10 M) being some three orders of magnitude lower than the binding constants of many soluble dehydrogenases for their nucleotides. It seems probable that the high affinity of dIII for nucleotides can be at least partly attributed to loop E, which folds down to form a lid over the ligand. In the complete transhydrogenase, however, the lid must open during the catalytic cycle to allow rapid exchange of NADP + and NADPH. Kinetic studies indicate that there is interconversion between the 'open' and 'occluded' states of dIII at key steps during catalysis [7, 10] . The disposition of two sets of amino acid residues, relative to the bound nucleotide, indicates an involvement in this interconversion.
Tyr890, Arg925 and Tyr1006 lie in an interesting position over the pyrophosphate group of the nucleotide (Figures 5,8 ). Tyr890 extends from the C terminus of β1. Tyr1006 is at the apex of loop E, in a β turn supported by a hydrogen bond between Gly1005 O and Ala1008 N. Both tyrosine residues are hydrogen bonded to the nucleotide pyrophosphate (although the interaction with Tyr1006 is weak). The guanidinium group of Arg925 is held between, and approximately equidistant from, the aromatic groups of the two tyrosyl sidechains by its hydrogen-bond contact with atoms in the ribose and the pyrophosphate groups of the bound NADP + , by van der Waals interactions (between the Cα atom of the arginine, and NC3 and NC7) and by Coulombic repulsion from the positively charged nicotinamide ring ( Figure 5 ).
Mutagenesis of the E. coli equivalent of Tyr1006 to phenylalanine resulted in only a 40% decline in the rate of uncoupled, reverse transhydrogenation, although substitution with leucine, histidine, asparagine or isoleucine led to virtually complete inhibition [40] . Evidently, the aromatic character of this residue is important in catalysis. In contrast to Tyr1006, replacement of the E. coli equivalent of Tyr890 with a number of different residues always caused some inhibition, although substantial activities often remained. Mutagenesis of the E. coli equivalent of Arg925 has only been studied in dI-dIII protein complexes, where substitution with cysteine had only small effects on transhydrogenation [24] ; experiments to change this residue in the complete enzyme, during the coupled reaction, should be revealing.
The invariant Asn966 and Asp967 in helix D are in hydrogen-bond contact with residues in the apex of loop E and with the pyrophosphate group of the nucleotide (Figures 5,8 ). In addition, Asp967 makes hydrogen bonds with two water molecules located between helix D and loop E. Although it is buried in the protein, Asp967 is not charge-compensated by an adjacent, basic sidechain. The equivalent of Asp967 in E. coli transhydrogenase has been replaced by site-directed mutagenesis. Reverse transhydrogenation in the complete enzyme was inactivated upon its substitution with a number of other residues [41] , whereas in dI-dIII complexes the reverse reaction was stimulated, and 'cyclic transhydrogenation' was only partially inhibited after replacement with cysteine [24] . Given that in dI-dIII complexes the reverse reaction is profoundly rate-limited by NADP + release, and the cyclic reaction does not obligatorily involve association/dissociation of NADP + /NADPH [8, 42] , this indicates a role for Asp967 in the interconversion between the open and occluded states. The nicotinamide ring of NADP + is exposed on a ridge of the dIII protein. The invariant residues Pro927, Val932 and Glu936 lie along the ridge, on one side of the nicotinamide ring, with Tyr1006 on the other side (at the apex of loop E). One surface adjacent to the ridge is composed of the strongly conserved hydrophobic residues of the nicotinamide-binding loop and of helix B, the turn between helix B and β3, and the mainly acidic C-terminal residues of helix C. The other surface is made up of several, strongly conserved residues involved in nucleotide binding -notably, Tyr890, Arg925 and Arg1000 and a group of mainly polar residues in the turn between β1 and helix A -and the invariant residues Lys1027 and Lys1028 in the loop between β6 and helix F. The guanidinium group of Arg925 is sandwiched between the tyrosyl groups of Tyr890 and Tyr1006. Protein atoms are in yellow and nucleotide atoms in red; the C4 atom of the nucleotide is shown in grey.
It is clear that there is a focus of hydrogen-bond interactions from Tyr890, Arg925 and Tyr1006, and from Asn966 and Asp967, to the pyrophosphate group of the NADP + . The expected single negative charge on the 5′-phosphate of the adenosine moiety (AP) is probably compensated by the positive charge of the guanidinium group of Arg925. The 5′-phosphate of the NMN moiety (NP) lies deeper within the core of the protein, however, and is some distance from any positively charged sidechain, although it makes hydrogen bonds with Gly924, Tyr890, Asn966 and Thr968 and a weak contact with Tyr1006.
Catalytic mechanism
In our binding-change mechanism [10, 11, 25] , the isolated form of dIII-NADP + corresponds to an occluded-state intermediate, which, in forward transhydrogenation, is poised ready for hydride transfer. In the complete protein, this intermediate is produced from the open state of dIII-NADP + as a result of protonation of dII-dIII from the p-phase (outside the mitochondrion or bacterium). Following hydride transfer from dI-NADH, occluded dIII-NADPH is then returned to the open state as a result of deprotonation of dII-dIII to the n-phase. To identify regions of the protein that undergo conformational changes during reduction of the nucleotide, changes in the magnetic environment of amide groups in R. rubrum dIII were monitored when bound NADP + was replaced with bound NADPH [37, 43] . In Figure 9 , residues, in which the backbone amide chemical shifts were perturbed by the nucleotide substitution are mapped on to the human dIII crystal structure. Not unexpectedly, in view of their proximity to the binding pocket of the nicotinamide ring, Gly889 and Tyr890 in the turn at the C terminus of β1, and residues from Ala923 through Met926, are affected by nucleotide reduction. Magnetic changes are also detected in a large number of residues located in helix D/loop D and loop E, but not elsewhere in the protein. Although changes in chemical shift cannot yet be precisely interpreted in structural terms, a conformational event originating in the nicotinamide ring is evidently transmitted from the binding pocket through the lid and the protruding front helix-loop. It is suggested that these events result from loss of positive charge on the nicotinamide ring upon reduction, which leads to local displacements in the amino acid triad (Tyr890, Arg925, Tyr1006) and hence to propagation of the conformational change through loop E, through helix D/loop D (Figure 9 ), to the interacting loops between the transmembrane helices of dII. A conformational change in the protein at the hydride transfer step is crucial to relay the information from the nucleotide pocket, to the H + -binding/translocation residue(s), that NADP + has become reduced, in order to trigger a change in H + access from one side of the membrane to the other. The observed conformational changes might represent part of this information relay.
The process of occlusion is central in energy coupling by transhydrogenase. It is required to allow the switch in the binding affinity of dIII for NADP + and NADPH to take place, and to facilitate hydride transfer [10, 11, 25] . If, as seems probable, occlusion is a result of the movement of loop E over the nucleotide, then the important region in the protein (centred on Asn966 and Asp967 in helix D) takes on a special significance (Figure 8 ). In this region there are numerous contacts with loop E, with the pyrophosphate and adenosine ribose groups of the bound ligand, and with the Tyr890, Arg925, Tyr1006 triad, and hence the nicotinamide-binding loop. It is envisaged that changes in ionisation/conformation in this region would lead to changes in the nucleotide-binding pocket that cause closure of the loop E lid, destabilise the NADP + relative to NADPH [25, 44] , and shift the nicotinamide ring into apposition with that of NADH on dI to allow hydride transfer. The fundamental question is how these ionisation/conformational changes are driven by proton translocation through dII. So far, biochemical experiments have failed to provide a clear indication as to the nature of the coupling [45] , but two possibilities are consistent with the crystal structure. Firstly, protons might be conducted from dII directly into the active centre of dIII around Asn966 and Asp967 to effect the nucleotide-binding change. It is interesting in this context that Asp967 and the NMN phosphate are inaccessible to solvent molecules, and both are involved in complex hydrogen-bond networks. Secondly, energy might be transmitted mechanically from dII to dIII via helix D/loop D, in a way that is analogous to rotation of the γ subunit in the transmission of energy between F 1 and F 0 of proton-translocating ATP synthase [46] ; here too, changes in nucleotide-binding affinity are crucial in the transduction process [9] . The subunit composition of transhydrogenase is not compatible with rotational catalysis, but other modes of movement of helix D/loop D can be considered. Experiments are underway to distinguish between these possibilities.
Biological implications
Transhydrogenase is found in the inner membranes of animal mitochondria and the cytoplasmic membranes of bacteria. It couples the transfer of reducing equivalents between NAD(H) and NADP(H) to proton translocation across the membrane. Under most physiological conditions transhydrogenase serves to drive the reduction of NADP + by NADH using the energy of the proton gradient generated by the respiratory chain. The NADPH is used in biosynthesis and in glutathione reduction, but transhydrogenase also has a role in controlling flux through the isocitrate dehydrogenase step in the tricarboxylic acid cycle. The mechanism by which transhydrogenase couples its redox reaction to proton pumping is not understood, although evidence suggests that a change in the affinity of the protein for NADP + and NADPH is central to energy transduction.
We describe here the first high-resolution structure of the recombinant, NADP(H)-binding component (dIII) of human heart transhydrogenase. The protein has the 'classical' Rossmann fold found in lactate dehydrogenase. It is a six-stranded β sheet flanked by helices. Its NADP + , however, is bound the 'wrong way round': the adenosine moiety is located in the second βαβαβ motif, Research Article Structure of transhydrogenase dIII White et al. 9
Figure 9
Conformational changes in dIII upon exchanging NADP + for NADPH. Amino acid residues from R. rubrum dIII for which backbone amide 15 N or 1 HN chemical shifts were significantly perturbed upon replacing bound NADP + with NADPH [37] are mapped in green on to a spacefilling model of the crystal structure of human dIII. Other protein atoms are in yellow and the nucleotide atoms are in red. The protruding helix D/loop D is shown at the bottom of the illustration. The figure was generated using TURBO-FRODO [50] . and the nicotinamide mononucleotide moiety in the first. The nicotinamide ring is exposed on a ridge of the protein, where, in the complete enzyme, it must approach the nicotinamide ring of NADH (on the dI component) to permit direct transfer of reducing equivalents. One interesting feature of dIII is helix D/loop D, which protrudes perpendicularly from the β sheet; this region probably interacts with the membrane-spanning dII component. A second interesting feature is loop E, which forms a 'lid' over the bound NADP + . There are numerous hydrogen-bond contacts between helix D/loop D, loop E and the pyrophosphate group of the nucleotide. Ionisation and conformational changes resulting from proton translocation through dII are evidently transmitted through helix D/loop D, causing opening and closing of the loop E lid and driving the switch in NADP(H)-binding affinity that is necessary for energy coupling.
Materials and methods

Protein preparation and crystallisation
The native dIII component of human heart transhydrogenase was cloned from cDNA, expressed in E. coli and purified, as described [5] . Crystals were grown using hanging-drop vapour diffusion (SJ Peake, JB Jackson and SA White, unpublished data). To obtain the selenomethionyl (SeMet) derivative of dIII the methionine auxotroph E. coli B834 (DE3) was transformed with pSJP2 [5] and cells grown in M9 minimal medium supplemented with SeMet and induced with 1.0 mM isopropylβ-D-thiogalactoside, as described [47] . The protein was purified and crystals were grown as for the native protein. The human dIII protein crystallises in the space group P4 1 
Data collection and processing
Diffraction data were collected at beamline ID14-4 of the European Synchrotron Radiation Facility (ESRF), Grenoble, using a Quantum 4 CCD detector system (ADSC, San Diego). Crystals were flash-cooled to 100K in the cryostream immediately prior to data collection. Three data sets were collected to 2.5 Å resolution from one SeMet crystal at wavelengths λ 1 = 0.9792 Å, λ 2 = 0.9794 Å and λ 3 = 0.9315 Å (corresponding to the inflection point, peak and remote wavelengths of the selenium K-edge, respectively). Initially, a 55º wedge of data was collected at each wavelength, followed by a second of 40º. Each diffraction image was a 1.0º oscillation with 1 s exposure. The time taken to collect the entire three-wavelength data set was 62 min. Data from a second crystal were collected to 1.9 Å (λ = 0.9315 Å) in two passes, covering low and higher resolutions. Data statistics are summarised in Table 1 (also see Supplementary material).
MAD phasing and model building
The structure of dIII was initially determined to 2.5 Å resolution by the multiwavelength anomalous dispersion (MAD) technique. SOLVE [48] was used to locate 14 out of a possible 18 selenium positions. The map was improved slightly by solvent flattening and histogram matching as incorporated in DM [49] . Secondary structure elements and clear protein-solvent boundaries were easily discerned in the map.
A polyalanine chain was fitted using the molecular graphics package TURBO-FRODO [50] . A total of 168 amino acid residues was built into one subunit. There was weak density at the N and C termini, but this could not be fitted with confidence. The selenium positions were used to help register the amino acid sequence to the polyalanine chain. Once sidechains were fitted in the first monomer, the model was rotated and translated to position the second monomer into density, using the selenium positions as a guide. NADP + was placed into the strong electron density at the C-terminal edge of the β sheet in each subunit. There was no ambiguity in the orientation of the NADP + molecule in either subunit, because of the strong electron density of the 2′-phosphate group branching off from the adenosine ribose.
Refinement
One round of simulated annealing refinement with noncrystallographic symmetry restraints was performed [51] against a maximum-likelihood target incorporating the observed MAD phases from SOLVE. Clear density at the N and C termini enabled the chain to be extended by seven and six amino acids, respectively, in both subunits. In addition, a frame-shift of +1 amino acids was identified in loops C and D. The model was further refined at 2.5 Å resolution using a combination of simulated annealing and Powell minimization, interspersed with manual adjustment of the model, using 2mF o -DF c and mF o -DF c electrondensity maps (SIGMAA-weighted [52] ), and a series of simulated annealing omit maps [53] . The real-space correlation coefficient [54] , calculated for each residue, was used to indicate problems in the structure that required attention. Noncrystallographic symmetry restraints were relaxed and then removed as differences between the two monomers, particularly at the N terminus, became apparent. A bulk-solvent correction was applied throughout to data from ∞ to 6 Å. Constant-temperature annealing, using torsion dynamics, was found to be particularly useful in refining the model [55] . When refinement was essentially complete to 2.5 Å, high-resolution data were incorporated, stepwise, until a complete 2.0 Å resolution data set was included. After further refinement, individual B factors were refined and solvent molecules were built in. Electron density for residues 837-858 could not be found in either monomer, clearly indicating disorder at the N terminus. The final model has 3004 nonhydrogen atoms, including 80 water molecules and two glycerol molecules. The crystallographic R factor is 23.7% with an R free of 25.8% (calculated with 5% of the data excluded from refinement). The model (364 amino acid residues, 6.6 (4.7) 6.7 (3.9) 4.2 (0.9) R sym (%) † 7.0 6.7 6.6 10.7 *Values given for I/σI are for all data. Values in parentheses are for data in the highest resolution shell. † R sym = Σ j |<I>-I j |/Σ<I>, where I j is the intensity of the jth reflection and <I> is the average intensity.
80 water molecules, two glycerol molecules and two sulphate ions) has good geometry with rmsd values for bonds and angles of 0.01 Å and 1.421º, respectively [56] . Model statistics are summarised in Table 2 . The data were indexed and integrated using Mosflm 6.0 [57] . Data were scaled and manipulated using the CCP4 suite of programs [58] . § Calculated for 180 equivalent Cα atoms.
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